1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

AbCellera Biologics Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2012

Location

Vancouver BC Canada

Primary Industry

Biotechnology

About

Founded in 2012 and based in Vancouver, Canada, AbCellera Biologics Inc. operates as a biotechnology company that develops and manufactures antibody therapeutics and vaccines, using microfluidic single-cell assays for immunization.
Current Investors
Data Collective, Innovation, Science and Economic Development Canada, OrbiMed Advisors

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopolymers, Bioinformatics, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development
Website
www.abcellera.com
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only

Deals

Deals Type
Add-on, Trade Sale
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Announced Invetx, Inc. 18 Jul 2024
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.